Amicus Therapeutics
FOLD
$9.33
Share price
3.21%
Change (1 day)
-16.70%
Change (1 year)
Categories
Market capitalization of Amicus Therapeutics (FOLD)
Market cap: $2.76 Billion
As of May 2024 Amicus Therapeutics has a market cap of $2.76 Billion. This makes Amicus Therapeutics the world's 3654th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Amicus Therapeutics from 2007 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $2.76 B | -33.59% |
| 2023 | $4.16 B | 21.3% |
| 2022 | $3.43 B | 6.59% |
| 2021 | $3.21 B | -46.51% |
| 2020 | $6.01 B | 141.86% |
| 2019 | $2.48 B | 37.12% |
| 2018 | $1.81 B | -24.17% |
| 2017 | $2.39 B | 238.25% |
| 2016 | $0.70 B | -41.67% |
| 2015 | $1.21 B | 52.54% |
| 2014 | $0.79 B | 445.88% |
| 2013 | $0.14 B | 9.49% |
| 2012 | $0.13 B | 11.58% |
| 2011 | $0.11 B | -26.5% |
| 2010 | $0.16 B | 80.19% |
| 2009 | $90 M | -49.27% |
| 2008 | $0.17 B | -25.77% |
| 2007 | $0.23 B |
End of Day market cap according to different sources
On May 14th, 2024 the market cap of Amicus Therapeutics was reported to be:
$2.76 Billion
$2.76 Billion
$2.76 Billion
$2.76 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $592.13 B | 21,326.79% | 🇩🇰 Denmark |
 Biogen BIIB | $33.03 B | 1,095.32% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $93.41 B | 3,280.40% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | $0.69 B | -74.88% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.42 B | -84.71% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $15.28 B | 453.11% | 🇺🇸 USA |